Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(15 sites)
France
CH Sud Francilien, Corbeil-Essonnes, Essonne Paris-Saclay hospital, Orsay, Essonne Antoine Beclère Hospital, Clamart, Haut de Seine Ambroise Paré hospital, Boulogne, Hauts de Seine Children-Teenager hospital, Nantes, Loire Atlantique Jeanne Flandre Hospital, Lille, Nord Robert Debré Hospital, Paris, Paris Robert Debré Hospital, Paris, Paris Meaux Hospital, Meaux, Seine et Marne Jean Verdier Hospital, Bondy, Seine St Denis Intercomunal Créteil Hospital, Créteil, Val de Marne Kremlin Bicêtre Hospital, Le Kremlin-Bicêtre, Val de Marne Andre mignot hospital, Le Chesnay, Yvelines GHEF Site Marne la vallée, Jossigny